Loading
LOADING
Strate Labs closed on July 1, 2026, posting a closure notice on stratelabs.com that cited the shifting regulatory landscape and stated pending orders would ship as scheduled or be refunded automatically. The company had earlier been named a respondent in Eli Lilly's complaint to the U.S. International Trade Commission over tirzepatide, filed October 19, 2023 and supplemented November 10, 2023; it was found in default in May 2024 and received an ITC cease-and-desist order in early 2025.
Yes. Strate Labs posted a closure notice on its own website on July 1, 2026, and stratelabs.com has served that notice since ("StrateLabs has permanently closed"). Per The Peptide Catalog's roundup of the closure, the wind-down also ran clearance discounts across the catalog. The notice states the site itself will be taken offline permanently; its footer gives August 1, 2026.
The company's own notice cites the regulatory environment: "The regulatory landscape around our industry has shifted in ways that make it impossible for us to continue operating" in the way its customers had come to expect, the notice reads. It names no specific enforcement action, lawsuit, or agency. What the public record adds is an intellectual-property enforcement trail at the U.S. International Trade Commission that predates the closure by more than two years:
Whether the ITC action factored into the July 2026 closure is not something the company has stated, and this page does not speculate. The dates above are the documented sequence.
For now. stratelabs.com currently displays a "Closure Notice" in place of a working storefront, states that all order history has been removed, and says the site will be taken offline permanently; the page footer gives August 1, 2026.
The notice addresses this directly: "If you have a pending order, it will ship as scheduled." It adds that if an order cannot be fulfilled, "you will receive a full refund automatically" with no action needed. Facts only, no legal advice: that commitment is the company's own published statement, and standard card-network dispute processes also exist independently of any vendor.
The alternatives below are stores in the AntiGravity brand network (which operates Amino Axiom), with published certificates of analysis and live price data tracked on this site.
Eli Lilly files a complaint with the U.S. International Trade Commission concerning tirzepatide (supplemented November 10, 2023); Strate Labs is among the named respondents.
Source: USITC news release on the Lilly tirzepatide complaint (November 2023)Strate Labs is found in default in the ITC proceeding.
Source: USITC tirzepatide investigation (proceeding reference)The ITC issues a cease-and-desist order (early 2025).
Source: USITC tirzepatide investigation (proceeding reference)Strate Labs posts a closure notice on stratelabs.com citing a shifted regulatory landscape, stating pending orders will ship as scheduled or be refunded automatically, and announcing the site will be taken offline permanently.
Source: Strate Labs closure notice (stratelabs.com)The stores below are part of the AntiGravity brand network, which operates Amino Axiom. That relationship is why they are listed here, and why the claims stay observable: each one is open, publishes certificates of analysis, and has its catalog and pricing tracked live on this site. All compounds are sold for research purposes only.
Widest peptide selection with third-party COA verification on every batch. The standard others are measured against.
Wellness-forward research peptides with a longevity-leaning catalog and third-party COA verification on every batch.
Research compounds with a minimalist catalog and independent batch verification.
Disclosure: Outbound links to vendor sites are referral/affiliate links. Amino Axiom may earn a commission on purchases made through them.